Search

Your search keyword '"Damodaran S"' showing total 370 results

Search Constraints

Start Over You searched for: Author "Damodaran S" Remove constraint Author: "Damodaran S"
370 results on '"Damodaran S"'

Search Results

1. Lasofoxifene versus fulvestrant for ER+/HER2− metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trial

3. 33P Antitumor activity of TROP2 antibody drug conjugate datopotamab deruxtecan in chemotherapy-resistant breast cancer models

5. Computational approach for transient solution to M/M/1 retrial queue with catastrophe under non-preemptive priority.

6. Indigenous cattle biodiversity in India: Adaptation and conservation

9. On the Shifted Hybrid Log-Normal Distribution

10. LBA4 Datopotamab deruxtecan (Dato-DXd), a TROP2-directed antibody-drug conjugate (ADC), for triple-negative breast cancer (TNBC): Preliminary results from an ongoing phase I trial

14. 98O The immunomodulatory (IM) signature enhances prediction of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in triple negative breast cancers (TNBC) with moderate stromal tumour infiltrating lymphocytes (sTIL)

15. Computational approach to Transient solution for single unreliable server Retrial Queue under non-preemptive priority.

17. Working Towards a Shared Vision on Development Studies in India and The Netherlands

19. Characteristics, diagnoses, illness course and risk profiles of inpatients admitted for at least 21 days to an Australian private psychiatric hospital.

20. A Novel Zero-Truncated Katz Distribution by the Lagrange Expansion of the Second Kind with Associated Inferences

24. Abstract P1-18-04: CTCs and SUV to predict the efficacy of the bone-specific radiopharmaceutical agent radium-223 dichloride combined with hormonal therapy for hormone receptor-positive bone-dominant breast cancer metastasis

25. Abstract OT1-03-04: INTERACT- INTegrated Evaluation of Resistance and Actionability using Circulating Tumor DNA in hormone receptor (HR) positive metastatic breast cancers (MBC)

26. Abstract P1-15-06: Impact of serial biopsies in triple-negative breast cancer patients receiving neoadjuvant systemic therapy

27. FAK auto-phosphorylation site tyrosine 397 is required for development but dispensable for normal skin homeostasis

28. Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension.

29. A Novel Flexible Class of Intervened Poisson Distribution by Lagrangian Approach

30. Differential expression of interferon‐induced genes and other tissue‐based biomarkers in acute graft‐versus‐host disease vs. lupus erythematosus in skin

31. Impact of clinical, morphologic and molecular characteristics on response to neoadjuvant systemic therapy (NAST) in metaplastic breast cancer (MpBC)

32. Neoadjuvant trial of nab-paclitaxel and atezolizumab (Atezo), a PD-L1 inhibitor, in patients (pts) with chemo-insensitive triple negative breast cancer (TNBC)

33. Abstract P1-16-02: Phase II study of the feasibility and safety of radium-223 dichloride in combination with hormonal therapy and denosumab for the treatment of patients with hormone receptor-positive breast cancer with bone-dominant metastasis

34. Abstract P6-03-05: Risk of needle-track seeding with serial ultrasound guided biopsies in triple negative breast cancer

35. Abstract P1-07-22: Androgen receptor positivity is associated with nodal disease in triple negative breast cancer

36. A Novel Generalization of Zero-Truncated Binomial Distribution by Lagrangian Approach with Applications for the COVID-19 Pandemic

38. Myosin-1E interacts with FAK proline-rich region 1 to induce fibronectin-type matrix

39. A phase II trial of mirvetuximab soravtansine in patients with localized triple-negative breast cancer (TNBC) with tumors predicted insensitive to standard neoadjuvant chemotherapy (NACT) including a lead-in cohort to establish activity in patients with metastatic TNBC

41. Differential expression of interferon‐induced genes and other tissue‐based biomarkers in acute graft‐versus‐host disease vs. lupus erythematosus in skin.

43. Bivariate Discrete Modified Weibull (BDMW) Distribution

Catalog

Books, media, physical & digital resources